Collaboration - June 4, 2015
AZ Might Consider CAR-T Firm
After AstraZeneca told Bloomberg it might be interested in a cancer therapy company, Juno Therapeutics’ stocks jumped by more than 15.3 percent this week, according to BioSpace.com. AstraZeneca’s CEO Pascal Soriot made the comments after he was asked whether his firm would be interested in a company like Juno, which develops ways the body can use its […]
Regulatory compliance - June 2, 2015
BMS Sues Exec Who Goes to AZ
Bristol-Myers Squibb has filed a lawsuit against a former executive for accepting a job with AstraZeneca, alleging he violated a non-compete agreement in the process, according to court documents. The executive, David Berman, who worked for Bristol-Myers for a decade, most recently was the vice president of the company’s immuno-oncology exploratory development team. He was promoted […]
Collaboration - April 15, 2015
LDC, Astra Expand Alliance
The Lead Discovery Center GmbH (LDC) and AstraZeneca have expanded their alliance to discover new medicines for the treatment of diseases with high unmet medical need, according to report published on BioSpace.com. Through an additional three-year period of collaboration, AstraZeneca expects to provide an extended set of high-quality compounds to the LDC’s internal screening collection […]
Acquisition - March 24, 2015
AZ Adopts e-Commerce Platform
Assay Depot, Inc., in conjunction with Astra Zeneca, recently developed and launched a preclinical research e-commerce platform called the AstraZeneca Innovation Marketplace (AIM). The program helps accelerate research and shorten the research cycle by automating legal and administrative processes. “AIM simplifies the purchase of preclinical services from our external partners. It will make our researchers’ […]
